View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Schizophrenia News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 21, 2023
1 min read
Save

Positive results in phase 2 trial of add-on drug for treatment-resistant schizophrenia

Positive results in phase 2 trial of add-on drug for treatment-resistant schizophrenia

A biopharmaceutical company has announced positive topline results from its phase 2, randomized, open-label trial of evenamide as an add-on to antipsychotic medication in those with moderate to severe treatment-resistant schizophrenia.

SPONSORED CONTENT
March 15, 2023
2 min read
Save

Motivational interview, CBT combination improves schizophrenia symptoms

Motivational interview, CBT combination improves schizophrenia symptoms

Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia compared with mindfulness sessions, according to findings published in The American Journal of Psychiatry.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
March 07, 2023
2 min read
Save

Inaugural cohort announced for startup collaboration on mental health initiatives

Inaugural cohort announced for startup collaboration on mental health initiatives

A mental health nonprofit has announced 11 companies will make up the inaugural cohort of a program that aims to help startups improve the lives of those with challenges relating to mental health conditions.

SPONSORED CONTENT
February 28, 2023
1 min read
Save

Accord Healthcare to offer generic schizophrenia, bipolar depression drug

Accord Healthcare to offer generic schizophrenia, bipolar depression drug

A generic pharmaceutical company announced the availability of a schizophrenia and bipolar depression treatment, according to a press release.

SPONSORED CONTENT
February 24, 2023
1 min read
Save

Psychiatric visits 146% higher for patients in year before MS onset

Psychiatric visits 146% higher for patients in year before MS onset

SAN DIEGO — Patients with MS were twice as likely to experience psychiatric morbidity, including depression and anxiety, in the prodromal phase compared with healthy controls, according to research presented at ACTRIMS 2023.

SPONSORED CONTENT
January 31, 2023
1 min read
Save

Nonadherence, switching, stopping antipsychotics linked to more acute care utilization

Nonadherence, switching, stopping antipsychotics linked to more acute care utilization

For individuals prescribed antipsychotic medication, nonadherence, along with switching and stopping medication, was associated with increases in acute care utilization, according to a study published in BMC Psychiatry.

SPONSORED CONTENT
January 30, 2023
2 min read
Save

Impaired motor skills may indicate psychosis for kids in families with psych disorders

Impaired motor skills may indicate psychosis for kids in families with psych disorders

In children with familial high risk of schizophrenia or bipolar disorder, evidence of motor impairment skills may indicate neurodevelopmental vulnerability for psychosis.

SPONSORED CONTENT
January 25, 2023
1 min read
Save

Needs of family members unmet with parent hospitalization for mental illness

Needs of family members unmet with parent hospitalization for mental illness

The needs of families are largely unmet when a parent is hospitalized for a mental illness, with the need for a broad range of care models required to address these gaps, according to a study published in BMC Psychiatry.

SPONSORED CONTENT
January 19, 2023
1 min read
Save

Affordable Care Act provisions reduced percentage of uninsured people with schizophrenia

The percentage of those with schizophrenia who were uninsured decreased after the Affordable Care Act provisions were implemented, researchers reported in JAMA Psychiatry.

SPONSORED CONTENT
January 17, 2023
1 min read
Save

FDA approves schizophrenia, bipolar treatment

FDA approves schizophrenia, bipolar treatment

The FDA has approved Rykindo for extended-release injectable suspension for the treatment of schizophrenia, as well as monotherapy or adjunctive therapy for the maintenance treatment of bipolar 1 disorder in adults.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails